Company intelligence
LIOM
The ultimate health wearable. Live consciously.
About LIOM
We remove the biggest pain in health – the pain of not knowing. Today's wearables track what you do and how you feel, but not the biochemistry that explains the why. LIOM closes that gap: we're building the ultimate health wearable for conscious living. It provides a continuous, needle-free window into your body's chemistry, starting with glucose. Through this, we empower users to make informed lifestyle choices and live healthier and longer lives. The science is proven. Developed over 8+ years by 50+ scientists, validated across 130+ subjects, and protected by 23 patent families, LIOM is the only company with the two critical pieces of innovation: calibration-free, non-invasive biomarker measurement and technology miniaturized into a wearable form factor. Founded in 2017 and based in Switzerland. Pre-orders open in 2027; launch in 2028. Reach out to discuss investment or partnership opportunities.
Verified activity
Signals from LIOM
3 published signals
Products & Services
LIOM will start with glucose at launch in 2028 and add additional biomarkers through over-air updates using the same underlying hardware platform over the first months.
Reported by Leo Grünstein
Products & Services
LIOM is building a continuous, needle-free window into your body’s chemistry using a hardware platform that will start with glucose and add additional biomarkers over time.
Reported by Leo Grünstein
Presence & Recognition
LIOM Chief Science & Innovation Officer Adler Perotte will speak at the MIT workshop on Non-invasive Glucose Monitoring in Cambridge MA on November 3-4
Reported by LIOM